Which drug best prevents eye muscle weakness from spreading? new study aims to find out
NCT ID NCT04182984
First seen Jan 31, 2026 · Last updated Jun 22, 2026 · Updated 25 times
Summary
This study looks at 200 adults with new-onset ocular myasthenia gravis, a condition that causes droopy eyelids and double vision. Researchers will compare different treatments, including steroids and immunosuppressants like azathioprine and tacrolimus, to see which works best and has the fewest side effects. The goal is to find the best way to keep the disease from spreading to other muscles and to improve daily life.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for OCULAR MYASTHENIA GRAVIS are added.
Genom att skicka in godkänner du våra Användarvillkor
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
Genom att skicka in godkänner du våra Användarvillkor
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Tangdu Hospotal
RECRUITINGXi'an, Shaanxi, China
Contact Phone: •••-•••-•••• Email: •••••@•••••
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
Active substance
Immunosuppressants (azathioprine, tacrolimus, mycophenolate mofetil), steroids, and symptomatic treatment (pyridostigmine bromide)
What this could lead to
If successful, this study could help identify which immunosuppressant works best for ocular myasthenia gravis, potentially reducing the risk of the disease spreading to other muscles.
What could go wrong
This is an observational study, not a controlled trial, so results may be influenced by patient and doctor choices. The findings may not apply to all patients, and immunosuppressants carry risks like infection and organ toxicity.
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.